Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Pediatr ; 194: 94-99, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29229450

RESUMO

OBJECTIVES: To provide further evidence regarding the relationship between obesity and gastroesophageal reflux disease (GERD) in children, through the use of 13C-octanoic acid breath test for gastric emptying time (GET) assessment and esophageal multichannel intraluminal impedance pH-testing (MII-pH). STUDY DESIGN: Obese children aged 4-17 years completed a questionnaire investigating reflux symptoms, the presence of functional gastrointestinal disorders, and quality of life. A subgroup of obese patients with and without GERD symptoms were asked to undergo 13C-octanoic acid breath test. Symptomatic patients were also required to undergo MII-pH. Age- and sex- matched asymptomatic nonobese children were enrolled as a comparison group. RESULTS: Of 113 enrolled patients, 44 (38.9%) reported reflux symptoms; 22 of the 44 underwent MII-pH. Their mean reflux index was 14.6%, and their mean number of daily reflux episodes was 51.8. The mean T½ GET of symptomatic was 107.6 minutes vs 116.5 minutes in asymptomatic obese children. Healthy nonobese children had a mean T½ GET of 100.1 minutes. The mean GET of symptomatic obese patients having >70 daily reflux events was 121.8 vs 87.6 minutes of patients with <70 daily reflux events (P <.05). Both symptomatic and asymptomatic obese patients had a worse quality of life than nonobese (P = 0.003 and P = 0.0002, respectively); a narrow waist circumference was directly related to GET (P = 0.01). CONCLUSIONS: A high percentage of obese children and adolescents experience GERD symptoms. GET was directly related to the narrow waist circumference of obese children with GERD and was significantly delayed in obese children with increased reflux events. Both symptomatic and asymptomatic obese patients had a worse quality of life compared with nonobese healthy patients.


Assuntos
Esvaziamento Gástrico/fisiologia , Gastroenteropatias/epidemiologia , Obesidade Infantil/complicações , Obesidade Infantil/fisiopatologia , Qualidade de Vida , Adolescente , Estudos de Casos e Controles , Criança , Monitoramento do pH Esofágico , Feminino , Gastroenteropatias/diagnóstico , Gastroenteropatias/fisiopatologia , Humanos , Masculino , Avaliação de Sintomas
2.
Ital J Pediatr ; 43(1): 76, 2017 Aug 30.
Artigo em Inglês | MEDLINE | ID: mdl-28854953

RESUMO

BACKGROUND: The term "humanization" indicates the process by which people try to make something more human and civilized, more in line with what is believed to be the human nature. The humanization of care is an important and not yet a well-defined issue which includes a wide range of aspects related to the approach to the patient and care modalities. In pediatrics, the humanization concept is even vaguer due to the dual involvement of both the child and his/her family and by the existence of multiple proposed models. OBJECTIVE: The present study aims to analyze the main existing humanization models regarding pediatric care, and the tools for assessing its grade. RESULTS: The main Humanization care programs have been elaborated and developed both in America (Brazil, USA) and Europe. The North American and European models specifically concern pediatric care, while the model developed in Brazil is part of a broader program aimed at all age groups. The first emphasis is on the importance of the family in child care, the second emphasis is on the child's right to be a leader, to be heard and to be able to express its opinion on the program's own care. Several tools have been created and used to evaluate humanization of care programs and related aspects. None, however, had been mutually compared. CONCLUSIONS: The major models of humanization care and the related assessment tools here reviewed highlight the urgent need for a more unifying approach, which may help in realizing health care programs closer to the young patient's and his/her family needs.


Assuntos
Atitude do Pessoal de Saúde , Enfermagem Familiar/organização & administração , Assistência ao Paciente/métodos , Pediatria/métodos , Brasil , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Avaliação de Resultados em Cuidados de Saúde , Poder Familiar/psicologia , Relações Médico-Paciente
3.
J Pediatr ; 167(6): 1440-2.e1, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26456739

RESUMO

We evaluated the effect of bowel preparation on colonic transit time (CTT) measured by the radio-opaque marker test in children with constipation. All children underwent 2 radio-opaque marker-CTT tests, both in cleansed and uncleansed bowel state. Our findings confirm that the state of colonic fecal filling may significantly influence CTT.


Assuntos
Catárticos/farmacologia , Colo/fisiopatologia , Constipação Intestinal/fisiopatologia , Trânsito Gastrointestinal/fisiologia , Adolescente , Criança , Pré-Escolar , Colo/efeitos dos fármacos , Constipação Intestinal/diagnóstico , Feminino , Humanos , Soluções Isotônicas , Masculino
4.
J Pediatr ; 161(4): 710-5.e1, 2012 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-22677568

RESUMO

OBJECTIVES: To compare the effectiveness of a mixture of acacia fiber, psyllium fiber, and fructose (AFPFF) with polyethylene glycol 3350 combined with electrolytes (PEG+E) in the treatment of children with chronic functional constipation (CFC); and to evaluate the safety and effectiveness of AFPFF in the treatment of children with CFC. STUDY DESIGN: This was a randomized, open label, prospective, controlled, parallel-group study involving 100 children (M/F: 38/62; mean age ± SD: 6.5 ± 2.7 years) who were diagnosed with CFC according to the Rome III Criteria. Children were randomly divided into 2 groups: 50 children received AFPFF (16.8 g daily) and 50 children received PEG+E (0.5 g/kg daily) for 8 weeks. Primary outcome measures were frequency of bowel movements, stool consistency, fecal incontinence, and improvement of other associated gastrointestinal symptoms. Safety was assessed with evaluation of clinical adverse effects and growth measurements. RESULTS: Compliance rates were 72% for AFPFF and 96% for PEG+E. A significant improvement of constipation was seen in both groups. After 8 weeks, 77.8% of children treated with AFPFF and 83% of children treated with PEG+E had improved (P = .788). Neither PEG+E nor AFPFF caused any clinically significant side effects during the entire course of the study period. CONCLUSIONS: In this randomized study, we did not find any significant difference between the efficacy of AFPFF and PEG+E in the treatment of children with CFC. Both medications were proved to be safe for CFC treatment, but PEG+E was better accepted by children.


Assuntos
Constipação Intestinal/tratamento farmacológico , Fibras na Dieta/administração & dosagem , Eletrólitos/uso terapêutico , Frutose/administração & dosagem , Laxantes/uso terapêutico , Polietilenoglicóis/uso terapêutico , Psyllium/administração & dosagem , Criança , Pré-Escolar , Combinação de Medicamentos , Eletrólitos/química , Feminino , Humanos , Laxantes/administração & dosagem , Masculino , Polietilenoglicóis/química , Estudos Prospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA